Bioasis Technologies Inc.
BIOAF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.7% | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | -48.3% | 74% | – | – |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -445.8% | -688% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -661.8% | -905.2% | – | – |
| EPS Diluted | -0.013 | -0.014 | -0.003 | -0.008 |
| % Growth | 9.4% | -334.4% | 59% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |